Teva Recalls Methylphenidate Hydrochloride Extended-Release Capsules Due to Dissolution Failure
Teva Pharmaceuticals is recalling 7,579 bottles of Methylphenidate Hydrochloride Extended-Release Capsules because routine stability testing revealed out-of-specification dissolution results.
- Product
- METHYLPHENIDATE HYDROCHLORIDE — METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide